Valvara brings objective, multi-modal tissue assessment to the point of care — actionable tissue health intelligence in a single handheld scan.
Clinicians managing lymphedema, post-surgical recovery, and chronic edema still rely on tape measures and subjective assessment — tools that miss subclinical changes until the window for early intervention has closed.
Valvara changes that. Our platform combines proprietary multi-modal sensing modalities into a single handheld scan, delivering a composite clinical index — quantitative tissue health data that enables earlier detection, smarter intervention, and measurable outcomes.
Multi-modal sensing in a single handheld device — validated against gold-standard clinical methods.
Our composite algorithm characterizes tissue fluid across depth layers — insight no single modality can provide alone.
Designed for the therapist's hands and the clinician's workflow — bringing objective tissue measurement to every visit, every patient.
Multi-modal sensing differentiates fluid compartments, tissue composition, and early pathological change.
Multi-frequency impedance measurement across a broad spectrum enables precise differentiation of tissue fluid compartments — delivering the quantitative data clinicians need for lymphedema assessment.
Core MeasurementLocalized tissue water content measurement at controlled depths complements spectral analysis with spatial resolution — together providing a complete picture of tissue fluid dynamics no single modality achieves alone.
Depth ProfilingValvara's proprietary algorithm fuses multi-modal data into a single composite index that characterizes tissue health across depth gradients — our core IP and clinical differentiator.
Proprietary AlgorithmA portable, clinician-owned wand that goes where the therapist goes — hospital, outpatient clinic, home visit, or satellite office. No floor-standing hardware. No hospital IT integration required.
Point of CareLongitudinal trend visualization, anomaly flagging, and structured clinical reports give care teams actionable tissue health intelligence without adding workflow burden.
Software / SaaSIntegrated environmental and contextual sensors enhance diagnostic accuracy and enable anatomically-aware tissue characterization.
Sensor ArchitectureThe clinicians treating lymphedema, post-surgical recovery, and chronic edema are working with tools built for a different era — or no objective tools at all. Valvara is building what tissue measurement should have been all along.
Valvara begins with lymphedema — the clearest clinical need and the most established bioimpedance evidence base. The platform is designed from day one to expand across conditions where tissue fluid dynamics and composition are clinically meaningful.
Primary indication · Early detection & staging
Adipose tissue differentiation · Disease monitoring
Recovery monitoring · Complication detection
Muscle mass tracking · Aging populations
Post-oncology lymphedema · Radiation sequelae
Expanding pipeline across oncology, nephrology & beyond
Platform expansion strategy covers 26+ clinical applications across 5 anatomical zones
Valvara is co-founded by a clinical expert who has treated lymphedema patients firsthand and a technical founder building the IP, engineering, and business infrastructure to bring this to market.
OTR/L, CLT-LANA. Certified lymphedema therapist with direct clinical experience treating the patients Valvara is built for. Drives clinical validation, customer discovery, and the go-to-market strategy rooted in real practitioner workflows.
Leads IP strategy, engineering partnerships, and business development. Architect of Valvara's patent portfolio spanning hardware, algorithms, clinical applications, and business methods.
A pre-seed SAFE round is underway. We're selective about partners — looking for investors with conviction in medical devices, point-of-care diagnostics, and clinician-led companies. Reach out for terms, diligence materials, and a conversation.
We review every inquiry personally and respond within 2 business days.
Reach us directly at
tbognanno@valvarainc.com